FBP1 Gene Curation
Gene-disease assertions not curated here (add link or write note):
Disease | Fructose-1,6-bisphosphatase deficiency |
---|---|
Inheritance | Autosomal recessive |
Prevalence |
Source: GeneReviews- “Fructose-1,6-bisphosphatase deficiency is rare. Approximately 150 affected individuals have been reported to date. An estimated prevalence of fructose-1,6-bisphosphatase deficiency is 1:350,000 in the Dutch population [Visser et al 2004] and <1:900,000 in the French population [Lebigot et al 2015]. The disorder may be more frequent in populations with higher rates of consanguinity [Santer et al 2016].” |
Rapid or full curation? | Rapid Full |
ClinGen- Only dosage sensitivity curated: Gene Associated with Autosomal Recessive Phenotype (30) GeneCC- AR fructose-1,6-bisphosphatase deficiency (Strong by Invitae, Genomics England PanelApp, and PanelApp Australia) OMIM- AR Fructose-1,6-bisphosphatase deficiency GeneReviews- Fructose-1,6-bisphosphatase deficiency NCBI - WWW Error Blocked Diagnostic | |
Clinical Validity Scoring Notes and points | Variant/Case Evidence: PMID 9382095 (Japanese cohort): c.960_961insG variant reported in 7 individuals with FBPase deficiency defined by <10% of FBPase activity levels. 3 of these individuals were homozygous (1 consanguineous family) and the remained 4 were compound het. Frameshift variant in last exon, possible escaped NMD. Two segregations in two unrelated families (1 segregation each) for this variant. (score= 9.5 points) c.530C>A (p.Ala177Asp)- Variant seen in trans with c.960_961insG in one proband. Only one allele in gnomAD v4. (0.5 point) c.490G>A (p.Gly164Ser)- Variant seen in 3 probands in trans with with c.960_961insG. Segregated in 1 individual in two unrelated families (1.5 pts) c.88G>T (p.Glu30Ter)- Homozygous in one consanguineous family(2 pts) Additional papers with case reports and FBP1 variants identified:
Segregation Evidence: Case/Control Evidence: Experimental Evidence: Source: |
Clinical Validity Points Total |
Source: |
Clinical Validity Classification Definitive (12pts) Strong (12pts) Moderate (7-11pts) Limited (0.1-6pts) No genetic evidence Refuted Disputed | Strong (12 pts) Source: |
Molecular Mechanism Loss of function Gain of function Dominant negative Unknown Other | Loss of function / Gain of function / Dominant Negative
|
Penetrance Complete (100%) High (≥80%) Moderate (<80% and >20%) Low (≤20%) (list source/PMID) |
Source: |
Age of Onset Congenital Pediatric Adolescent Adulthood Late adulthood (list source/PMID) |
|
Severity Embryonic lethal - presence of a pathogenic variant or variants is not compatible with life. The penetrance must be complete. |
|
Clinical Features |
Sources: |
HPO Terms |
|
Gene SOPs & Notes | LINK if SOP is a long document. Short notes if it is easy to digest. eg. Last known truncating variant |
Curation Summary - The @GENE@ is associated with @inheritance pattern@ @condition@, which is characterized by @clinical features@ (PMIDs). - Variable expression or severity: - Limited evidence gene: The PCNA gene has been reported in individuals with early onset autosomal recessive ataxia (PMID: 33426167, 24911150), however, evidence supporting this gene-dIsease relationship is limited |
|
Case ID, Curator name, Date, Jira ticket link |
|